In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcatheter aortic-valve replacement or surgical aortic-valve replacement. PARTNER 3: https://t.co/LNVJq3oQ5k Evolut Low Risk: https://t.co/F1Bp7a2qR5 https://t.co/TLiym2WSFK
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2014 – May 2024Where it's discussed
-
X / Twitter153 posts
-
News74 articles
-
YouTube4 videos
-
Blogs4 articles
-
Facebook2 posts
-
Bluesky1 posts
AI synopsis
What people are saying
An analysis of the social discussions reveals a strong consensus endorsing the study's results, using words like 'ground-breaking' and 'game changer,' which reflect excitement and perceived transformative impact on how aortic stenosis might be treated in low-risk populations. The references to specific trials and the frequent sharing of abstracts and outcomes demonstrate high engagement and recognition of the study's substantial influence in the medical community.
The discussions highly favor the findings, emphasizing that TAVR is a safe and effective alternative for low-risk patients, supporting the publication's conclusions.
Many social discussions express curiosity and excitement about the trials' results, indicating strong engagement with the topic.
Posts reference specific trials (PARTNER 3, Evolut Low Risk) and outcomes, showing in-depth understanding and active discussion about the research implications.
The widespread sharing, use of phrases like 'game changer,' and references to future treatment protocols suggest these reports could significantly influence clinical practice and decision-making.
Abstract in brief
- TAVR is a minimally invasive procedure for severe aortic stenosis and is being studied as an alternative to surgery, especially in low-risk patients.
- A clinical trial assessed TAVR against traditional surgical aortic-valve replacement in 850 low-risk patients, focusing on the rates of death or disabling stroke at 24 months.
- Results showed TAVR had comparable outcomes to surgery, with lower rates of certain complications and better valve performance at 12 months, indicating it is a safe option for low-risk patients.
Top posts
Most liked on X and BlueskyIn the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either TAVR with a self-expanding valve or surgical aortic-valve replacement. Read the full abstract: https://t.co/F1Bp7a2qR5
Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5 Editorial: Informed Shared Decisions for Patients with Aortic Stenosis https://t.co/YMbqFu9TDp https://t.co/NRMdYtvEEY
ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/vnUaTtHg1Y
A PERMANENT CHANGE IN HOW WE MANAGE AORTIC STENOSIS Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/xlqciBsTE6
All mentions
Key Findings from ACC 2019: Cardiology Insights
This week's episode of 'Café com Journal' summarizes key articles presented at the American College of Cardiology 2019 conference. Key topics include immediate vs. delayed coronary angiography for cardiac arrest…
TAVR vs SAVR: Outcomes and Innovations in Cardiology
The DEDICATE trial compares TAVR and SAVR in low-risk patients. TAVR demonstrated superior outcomes, including lower death and stroke rates and quicker recovery. This podcast delves into these findings and discusses…
Insights on PCI for Ischemic Left Ventricular Dysfunction Trends
This week, John Mandrola MD discusses key findings on whether percutaneous coronary intervention enhances survival and heart function in patients with severe ischemic left ventricular dysfunction compared to standard…
Sudden Cardiac Death in Sports and Coffee's Health Effects
This week, we discuss exercise-related sudden cardiac death and new findings in TAVI data. The podcast also explores the health effects of coffee on cardiac activity and physical performance. Join John Mandrola, MD, for…
RT @mirvatalasnag: #PartnersInLearning #TVTConnect #TVT2020 #PCReCourse @PCRonline @TCTMD @crfheart
#PartnersInLearning #TVTConnect #TVT2020 #PCReCourse @PCRonline @TCTMD @crfheart
@DrAlanaziH Even in low surgical risk https://t.co/eorh7PPhPj https://t.co/80TrQKXH8n
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/IOKx5FZssj
Evolut Low Risk Trial Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/f2wTsGJcjE https://t.co/DRISWd87Ma
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/NizeAZcW6z
RT @hahn_rt: Findings of the 2 Low-Risk TAVR Trials: Balloon-Expandable Valve in Low-Risk Patients https://t.co/IRsit3ulPb Self-Expanding…
A PERMANENT CHANGE IN HOW WE MANAGE AORTIC STENOSIS Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/xlqciBsTE6
RT @YaleIMed: Dr. John Forrest et al published, “Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients” i…
.@drklam starts #GeriMedJC with article on Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. https://t.co/cp39icPOUE View #GeriMedJC live: https://t.co/hBLlhNABze
Remember use hashtag #GeriMedJC in your tweets. Starting in 1 min! Short article is @NEJM study Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/cp39icydw4
RT @GeriMedJC: Join #GeriMedJC May 31 at 08:00 ET for discussion on @NEJM study: Transcatheter Aortic-Valve Replacement with a Self-Expandi…
Join #GeriMedJC May 31 at 08:00 ET for discussion on @NEJM study: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. View live on @zoom_us https://t.co/hBLlhNABze
[trend] up+16: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] new: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+10: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] new: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+2: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+2: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+7: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+8: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+19: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+10: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
RT @YaleIMed: Dr. John Forrest et al published, “Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients” i…
RT @YaleIMed: Dr. John Forrest et al published, “Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients” i…
RT @YaleIMed: Dr. John Forrest et al published, “Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients” i…
[trend] up+4: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdwEQ7
RT @YaleIMed: Dr. John Forrest et al published, “Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients” i…
[trend] up+4: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/zEASuhl79B
@ADAlthousePhD @venkmurthy @HenryJOncology @NEJM @VPrasadMDMPH @oncology_bg Here are 2 other NEJM papers with Bayesian posterior probabilities... https://t.co/jssJNJFmpq https://t.co/kvaclvtjzz
[trend] up+17: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+8: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+20: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+20: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
[trend] up+22: *Popma JJ* et al (N Engl J Med) **Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.** https://t.co/LVrvgdOgeH
RT @jonnywatt: PARTNER 3 and Evolut Low Risk trials published in NEJM this week. Truly ground-breaking outcomes for TAVI vs. SAVR in low ri…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
RT @NEJM: In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcathet…
In two RCTs, patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either transcatheter aortic-valve replacement or surgical aortic-valve replacement. PARTNER 3: https://t.co/LNVJq3oQ5k Evolut Low Risk: https://t.co/F1Bp7a2qR5 https://t.co/TLiym2WSFK
RT @jonnywatt: PARTNER 3 and Evolut Low Risk trials published in NEJM this week. Truly ground-breaking outcomes for TAVI vs. SAVR in low ri…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @jonnywatt: PARTNER 3 and Evolut Low Risk trials published in NEJM this week. Truly ground-breaking outcomes for TAVI vs. SAVR in low ri…
PARTNER 3 and Evolut Low Risk trials published in NEJM this week. Truly ground-breaking outcomes for TAVI vs. SAVR in low risk patients with severe aortic stenosis. https://t.co/VSrMV1k2qW https://t.co/fGqGPWXHYu https://t.co/8ejFGxIdK0
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/zCO90GA3RE
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
RT @NEJM: Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5…
Original Article: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/F1Bp7a2qR5 Editorial: Informed Shared Decisions for Patients with Aortic Stenosis https://t.co/YMbqFu9TDp https://t.co/NRMdYtvEEY
@wannaacongenita @OP_PAiNKiLLER なんだかlow riskでもTAVIが非劣勢のようですね。準緊急でTAVI+PCIはないと思いますが、最近のTAVIの適応拡大は押せ押せですね… 今後どうなるんだろう。 https://t.co/vSvhUCt3zR
#TAVR #Aorta #AorticValve #TranscatheterAorticValveReplacement with a Self-Expanding Valve in Low-Risk Patients | #NEJM https://t.co/C4kvdkbEIW
@NEJM Despite these (& others) complications as a non-cardiologist w #ClinicalTrials like PARTNER 3 https://t.co/gFfDoKOYzj & https://t.co/7J8iR2WBw7 the message I get is that #TAVR is preferable to surgical #AVR repair in low risk patients
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/Yc4NgRPBGE
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/UPigXbTJNC
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
RT @NEJM: In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned…
In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either TAVR with a self-expanding valve or surgical aortic-valve replacement. Read the full abstract: https://t.co/F1Bp7a2qR5
RT @ericjvelazquez: Congratulations to the Evolut Low Risk Trial Investigators including Yale’s own John Forrest for expanding options for…
RT @jacabreracardio:
RT @jacabreracardio:
RT @FMakhdom: دراستين تثبت فعالية تغيير الصمام الاورطي بالقسطرة في الاجتماع السنوي لجمعية القلب الأمريكية https://t.co/B2SC2rWbbI
RT @FMakhdom: دراستين تثبت فعالية تغيير الصمام الاورطي بالقسطرة في الاجتماع السنوي لجمعية القلب الأمريكية https://t.co/B2SC2rWbbI
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/RfuGW1SpZv
TAVR is not usually performed in patients at low surgical risk. This article shows that TAVR with a self expanding supraannular bioprosthesis can be a good alternative to surgery in patients who have severe aortic stenosis and low surgical risk. #biom4180 https://t.co/GHkz7lyynF
RT @ericjvelazquez: Congratulations to the Evolut Low Risk Trial Investigators including Yale’s own John Forrest for expanding options for…
Mounting evidence that TAVR is a good option even for low-risk surgical candidates: https://t.co/A3kM3I3IRX https://t.co/tAmFbzLEIs
RT @2minmed: #VisualAbstract: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/6yslQnxV…
#VisualAbstract: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/6yslQnxVqw #StudyGraphics #TranscatheteraorticvalvereplacementTAVR https://t.co/W8ZeDEfmw7
RT @MAecocardio: #ACC2019 Sin duda las cosas van a cambiar en el tratamiento de la Estenosis Aortica con TAVI en pacientes de bajo riesgo h…
@hopeforfuture3 @kpp1967 @RogueRad No but a study came out in NEJM recently showing non inferior outcomes of TAVR in low risk patients with a number of significant safety outcomes being better https://t.co/THyYoeHpm2
RT @manuel_carnero: https://t.co/mcaWhhZ3nb Evolut low risk trial. Cómo es posible publicar en New England los resultados intermedios de 78…
RT @TKDsosyal: In patients w/ severe aortic stenosis who are deemed to be at a low surgical risk TAVR w/ a self-expanding valve found to be…
RT @manuel_carnero: https://t.co/mcaWhhZ3nb Evolut low risk trial. Cómo es posible publicar en New England los resultados intermedios de 78…
RT @hahn_rt: Findings of the 2 Low-Risk TAVR Trials: Balloon-Expandable Valve in Low-Risk Patients https://t.co/IRsit3ulPb Self-Expanding…
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/HaeYYTCUIa
RT @hahn_rt: Findings of the 2 Low-Risk TAVR Trials: Balloon-Expandable Valve in Low-Risk Patients https://t.co/IRsit3ulPb Self-Expanding…
RT @MAecocardio: #ACC2019 Sin duda las cosas van a cambiar en el tratamiento de la Estenosis Aortica con TAVI en pacientes de bajo riesgo h…
RT @MAecocardio: #ACC2019 Sin duda las cosas van a cambiar en el tratamiento de la Estenosis Aortica con TAVI en pacientes de bajo riesgo h…
RT @MAecocardio: #ACC2019 Sin duda las cosas van a cambiar en el tratamiento de la Estenosis Aortica con TAVI en pacientes de bajo riesgo h…
RT @hahn_rt: Findings of the 2 Low-Risk TAVR Trials: Balloon-Expandable Valve in Low-Risk Patients https://t.co/IRsit3ulPb Self-Expanding…
RT @MAecocardio: #ACC2019 Sin duda las cosas van a cambiar en el tratamiento de la Estenosis Aortica con TAVI en pacientes de bajo riesgo h…
RT @ericjvelazquez: Congratulations to the Evolut Low Risk Trial Investigators including Yale’s own John Forrest for expanding options for…
RT @hahn_rt: Findings of the 2 Low-Risk TAVR Trials: Balloon-Expandable Valve in Low-Risk Patients https://t.co/IRsit3ulPb Self-Expanding…
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/jqpfVA6Bjp
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/RnUNc9WfLY
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/MHRZemp6yq
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/oOUXpjLC6E
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/GC92uV1bpV
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/faHG9quWlG
RT @PPibarot: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/Hxu4iKXQjq
RT @foroic: ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low…
RT @foroic: ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low…
RT @PPibarot: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/Hxu4iKXQjq
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/Hxu4iKXQjq
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients #NEJM https://t.co/BYSEtvzVjR
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/NY3nhbh9de
RT @Ortega_Paz: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | @NEJM https://t.co/3wmWsSZt5o #TA…
RT @Ortega_Paz: Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | @NEJM https://t.co/3wmWsSZt5o #TA…
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/KFflP8gUmw
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | @NEJM https://t.co/3wmWsSZt5o #TAVR https://t.co/opPS0KODty
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/HvHVKlF2EC
RT @foroic: ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low…
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/mir0NYqtiA
Transcatheter self-expanding supraannular bioprostheses are non-inferior to surgical AVR in patients with low surgical risk at 2 years. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/SEyqIZmDiR
Game changer? Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/nMQufBnpsm
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/kjMbS79qV7
RT @foroic: ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low…
RT @foroic: ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low…
Another critically important trial. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/l5s6f1JuQT
ACC Boom #2 Also CoreValve in Low Risk Public results Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/vnUaTtHg1Y
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/L6a4jtXxXc
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients | NEJM https://t.co/iEsVaYYJH6
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/tcJgc4qV34
#ACC19 Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients https://t.co/G11xs0yHby
Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis — NEJM
AM